<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01802268</url>
  </required_header>
  <id_info>
    <org_study_id>0468E8-3328</org_study_id>
    <nct_id>NCT01802268</nct_id>
  </id_info>
  <brief_title>Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients</brief_title>
  <official_title>Outcomes of Planned Conversion From Tacrolimus to Sirolimus-based Immunosuppressive Regimen in de Novo Kidney Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helio Tedesco Silva Junior</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital do Rim e Hipertensão</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background Early conversion from calcineurin inhibitor to mammalian target of rapamycin
      inhibitor is one of the immunosuppressive strategies that have been investigated to mitigate
      long-term CNi associated adverse events. This study aims to evaluate the conversion from
      tacrolimus to sirolimus in de novo kidney transplant recipients.

      This multicenter, open-label study, planned to enroll 297 patients initially treated with
      tacrolimus, enteric-coated mycophenolate sodium (1440 mg/day, orally) and prednisone. The
      primary objective is to show superior glomerular filtration rate in the SRL group at 24
      months after transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal Function calculated using the 4 variable MDRD formula</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival free from first treated biopsy confirmed acute rejection episodes (tBCAR) &gt; IA according to Banff 1997 classification.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of all treated acute rejections.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence and severity of all tBCAR.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient and graft survival.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of treatment discontinuation</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">320</enrollment>
  <condition>Kidney Transplant</condition>
  <arm_group>
    <arm_group_label>Sirolimus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conversion from Tacrolimus to Sirolimus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tacrolimus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Maintenance on tacrolimus</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Conversion from Tacrolimus to Sirolimus</intervention_name>
    <arm_group_label>Sirolimus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Maintenance on tacrolimus</intervention_name>
    <arm_group_label>Tacrolimus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients older than 18 years,

          -  recipients of first kidney transplant from brain dead deceased or living related
             non-HLA identical donors not older than 65 years,

          -  patients had to receive an ABO compatible organ with a CDC negative crossmatch and a
             peak panel reactive antibody lower that 30%,

          -  all patients agreed to use contraceptive methods during the study and up to 3 months
             after study drug discontinuation.

        Exclusion Criteria:

          -  patients with chronic kidney diseases due to focal and segmental glomerulosclerosis
             and membranoproliferative glomerulonephritis,

          -  patients with active infection or positive for hepatitis B or C or human
             immunodeficiency viruses,

          -  patients with previous history of malignancy,

          -  patients with significant hematological or metabolic laboratorial abnormalities.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helio T. Silva Junior, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nephrology Division, Hospital do Rim, Federal University of São Paulo, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudia R. Felipe, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Nephrology Division, Hospital do Rim, Federal University of São Paulo, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valter D. Garcia, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Kidney &amp; Pancreas Transplant Unit, Santa Casa de Misericordia, Porto Alegre, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elias D. Neto, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Renal Transplant Service, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario A. Filho, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto de Urologia e Nefrologia &amp; Medical School-FAMERP/HB-FUNFARME, São José do Rio Preto-SP, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabiana LC Cortieri, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital University Evangélico de Curitiba, Curitiba, Parana, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Deise BM Carvalho, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Nephrology Service, Bonsucesso General Hospital. Rio de Janeiro, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose OM Pestana, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Nephrology Division, Hospital do Rim, Federal University of São Paulo, Brazil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital University Evangélico de Curitiba, Curitiba, Parana, Brazil</name>
      <address>
        <city>Curitiba</city>
        <state>Paraná</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kidney &amp; Pancreas Transplant Unit, Santa Casa de Misericordia, Porto Alegre, Brazil</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Urologia e Nefrologia &amp; Medical School-FAMERP/HB-FUNFARME, São José do Rio Preto-SP, Brazil</name>
      <address>
        <city>São Jose do Rio Preto</city>
        <state>São Paulo</state>
        <zip>04038</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nephrology Service, Bonsucesso General Hospital. Rio de Janeiro, Brazil</name>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nephrology Division, Hospital do Rim, Federal University of São Paulo, Brazil</name>
      <address>
        <city>São Paulo</city>
        <zip>04038</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renal Transplant Service, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.</name>
      <address>
        <city>São Paulo</city>
        <zip>04038</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2013</study_first_submitted>
  <study_first_submitted_qc>February 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2013</study_first_posted>
  <last_update_submitted>February 27, 2013</last_update_submitted>
  <last_update_submitted_qc>February 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital do Rim e Hipertensão</investigator_affiliation>
    <investigator_full_name>Helio Tedesco Silva Junior</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>sirolimus</keyword>
  <keyword>tacrolimus</keyword>
  <keyword>early conversion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
    <mesh_term>Sirolimus</mesh_term>
    <mesh_term>Everolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

